HeyJaredChristos Evangelou
- Indexed articles, last 90 days
- 1
- Latest publication
- Sep 23, 2026
- Outlet visibility, for Medscape
- Top 50K sites
- Earliest in this view
- Sep 23, 2026
Latest articles
PET-Guided Nivolumab Strategy Shows Early Response in HL (opens the original)
Read excerpt
A PET-adapted treatment strategy that combines nivolumab with intensive chemotherapy produced early metabolic responses in patients with newly diagnosed, advanced-stage classical Hodgkin lymphoma (HL), interim results from a small study showed. All of the 35 patients who completed treatment had a complete metabolic response by the end of therapy, with 83% having achieved this result after two cycles of induction therapy. “The depth and kinetics of early metabolic and anatomic response in our coh
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 50K sites
For Medscape, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.